HOME >> BIOLOGY >> NEWS
ACS News Service Weekly PressPac -- Nov. 22, 2006

Here is the latest American Chemical Society (ACS) News Service Weekly press package (PressPac) with reports selected from 35 major peer-reviewed journals and Chemical & Engineering News.


ACS NEWS SERVICE Weekly PressPac − ALL CONTENT IS FOR IMMEDIATE USE EXCEPT ARTICLE #5 (EMBARGOED FOR 9 A.M., EASTERN TIME, NOV. 27, 2006)


In This Edition:

  • Toward improved medications for iron-overload diseases

  • Fostering a new medical life for a forgotten antibiotic

  • Engineering the "Super Enzyme" -- a potential new weapon against heart disease

  • The semantics on the next revolution in online scientific publishing

  • A continued erosion in United States' share of global R&D publications

  • Journalists' Resources: Landmarks, news sources and more

  • Mark Your Calendars: Chemistry's growing role in cancer research


ARTICLE #1 FOR IMMEDIATE RELEASE

Toward new medications for iron-overload diseases
Journal of Medicinal Chemistry

Scientists report progress in developing much-needed new medications for hemochromatosis and other iron-overload diseases. In these conditions, excess amounts of iron accumulate in the liver, heart, pancreas and other organs and eventually cause serious damage.

Raymond J. Bergeron and colleagues at the University of Florida explain that existing treatments remove only small amounts of iron from sensitive organs like the heart. Treatment sometimes must continue for years to remove enough iron to prevent organ damage, they note in a report scheduled for the current (Nov. 16) issue of the ACS Journal of Medicinal Chemistry, a biweekly publication.

The researchers report the synthesis and early testing in laboratory animals of a possible new generation of iron chelating drugs, compounds that remove excess iron from the body. In addition to working more ef
'"/>

Contact: Michael Woods
M_Woods@acs.org
202-872-4400
American Chemical Society
27-Nov-2006


Page: 1 2 3 4 5 6

Related biology news :

1. ACS News Service Weekly PressPac -- May 23, 2007
2. ACS News Service Weekly PressPac -- May 16, 2007
3. ACS News Service Weekly PressPac -- May 9, 2007
4. ACS News Service Weekly PressPac -- May 2, 2007
5. ACS News Service Weekly PressPac -- April 25, 2007
6. ACS News Service Weekly PressPac -- April 18, 2007
7. ACS News Service Weekly PressPac -- April 11, 2007
8. ACS News Service Weekly PressPac -- March 28, 2007
9. ACS News Service Weekly PressPac -- March 21, 2007
10. ACS News Service Weekly PressPac -- March. 14, 2007
11. ACS News Service Weekly PressPac -- Feb. 21, 2007

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/6/2020)... ... May 06, 2020 , ... ... will become the latest out-of-state company to partner with the device accelerator ... has developed a point-of-care analyzer capable of accurately performing enzyme-linked immunosorbent assays ...
(Date:5/1/2020)... ... April 30, 2020 , ... InBios International Inc., a leading ... been awarded a contract from the Biomedical Advanced Research and Development Authority (BARDA), ... the U.S. Department of Health and Human Services, to develop the SCoV-2 Detect ...
(Date:4/30/2020)... ... April 28, 2020 , ... ... Lachman Consultants latest effort in providing timely and critical information to life science ... social distancing and health safety concerns. , “Providing the most up-to-date actionable guidance ...
Breaking Biology News(10 mins):
(Date:5/21/2020)... ... May 19, 2020 , ... Eaton Square is pleased ... of Popper and Company, a biotechnology and medical technology-focused strategy and M&A advisory firm. ... in the United States, linking US and Asia Pacific healthcare innovators with capital and ...
(Date:5/15/2020)... ... May 14, 2020 , ... ... multiple open heart surgeries before becoming adults. The reason: there are ... address this critical unmet need, the Department of Defense has awarded Draper, Boston ...
(Date:5/14/2020)... ... May 12, 2020 , ... DuPont Nutrition & ... partner for all personal care ingredients in Russia and Belarus. Beginning May 1, ... portfolio for personal care. , The GENENCARE®OSMS product line contains a ...
(Date:5/14/2020)... ... May 13, 2020 , ... Early stages of ... little or no information on the drug’s mechanism of action (MOA). Gene expression ... by measuring the activity of molecular pathways. This information can complement phenotypic readouts ...
Breaking Biology Technology:
Cached News: